Recent changes in endometrial cancer trends among menopausal-age US women
- 31 August 2013
- journal article
- Published by Elsevier BV in Cancer Epidemiology
- Vol. 37 (4), 374-377
- https://doi.org/10.1016/j.canep.2013.03.008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Trends in Endometrial Cancer Incidence by Race and Histology with a Correction for the Prevalence of Hysterectomy, SEER 1992 to 2008Cancer Epidemiology, Biomarkers & Prevention, 2013
- Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?International Journal of Cancer, 2012
- Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countriesJournal of Epidemiology and Community Health, 2011
- Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-AnalysisCancer Epidemiology, Biomarkers & Prevention, 2010
- Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. WomenCancer Epidemiology, Biomarkers & Prevention, 2010
- Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast CancerAnnals of Internal Medicine, 2009
- Novel molecular profiles of endometrial cancer—new light through old windowsThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- The Decrease in Breast-Cancer Incidence in 2003 in the United StatesThe New England Journal of Medicine, 2007
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002